May 20, 2024

Pet Diabetes Care Devices Market Size, Report by 2033

The global pet diabetes care devices market size surpassed USD 2.48 billion in 2023 and is projected to hit around USD 4.91 billion by 2033, growing at a CAGR of 7.05% from 2024 to 2033.

Key Points

  • North America held the largest market share of 37% in 2023.
  • The Asia-Pacific region is observed to witness the fastest rate of expansion during the forecast period.
  • By device, the insulin delivery devices segment has contributed more than 93% of the market share in 2023.
  • By animal, the dogs segment led the market with the major market share of 55% in 2023.
  • By end-users, the veterinary hospitals segment has recorded more than 42% of the market share in 2023.

Pet Diabetes Care Devices Market Size 2024 to 2033

The Pet Diabetes Care Devices Market is witnessing steady growth due to the increasing prevalence of diabetes among pets, advancements in veterinary medicine, and rising pet healthcare expenditure. Diabetes mellitus, a chronic metabolic disorder, affects a significant number of pets worldwide, particularly dogs and cats. As pet owners become more aware of diabetes and its management, the demand for pet diabetes care devices, including blood glucose monitoring systems, insulin delivery devices, and other related products, continues to rise. This market offers opportunities for manufacturers, veterinarians, and pet owners to improve the quality of life for diabetic pets and ensure better disease management.

Get a Sample: https://www.precedenceresearch.com/sample/3970

Growth Factors:

Several factors contribute to the growth of the Pet Diabetes Care Devices Market. Firstly, the increasing prevalence of pet obesity and sedentary lifestyles has led to a rise in the incidence of diabetes among pets. Factors such as improper diet, lack of exercise, genetic predisposition, and environmental factors contribute to the development of diabetes in pets, driving the demand for diabetes care devices and management solutions.

Moreover, advancements in veterinary medicine, including improved diagnostic techniques, better understanding of diabetes pathophysiology, and development of novel treatment options, have led to enhanced management of pet diabetes. Veterinary professionals are increasingly incorporating glucose monitoring systems, insulin delivery devices, and other innovative technologies into their practice to provide better care for diabetic pets, thereby boosting the demand for pet diabetes care devices.

Furthermore, the growing pet humanization trend, characterized by increased spending on pet healthcare and wellness, is driving the adoption of advanced medical devices for pet care. Pet owners are willing to invest in high-quality products and services to ensure the health and well-being of their furry companions, including those diagnosed with diabetes. This trend has created a lucrative market for pet diabetes care devices, as pet owners seek effective and convenient solutions for managing their diabetic pets’ condition.

Additionally, the expanding pet insurance coverage and reimbursement options for veterinary care, including diabetes management, are facilitating greater access to diabetes care devices for pet owners. Insurance providers are increasingly covering the costs of diabetes-related treatments and devices, encouraging pet owners to seek appropriate care and invest in diabetes management solutions for their pets.

Furthermore, technological advancements in pet diabetes care devices, such as the development of continuous glucose monitoring systems, smart insulin pumps, and telemedicine platforms, are revolutionizing the management of pet diabetes. These innovative devices offer real-time monitoring, personalized treatment adjustments, and remote consultations, enabling more efficient and convenient diabetes management for both veterinarians and pet owners.

Region Insights:

The Pet Diabetes Care Devices Market exhibits regional variations influenced by factors such as pet population demographics, pet healthcare infrastructure, veterinary regulations, and socio-economic factors. In North America, particularly the United States and Canada, the market is well-developed due to the high pet ownership rates, advanced veterinary healthcare services, and strong market presence of leading pet diabetes care device manufacturers. The region’s robust pet insurance coverage and reimbursement policies further support the adoption of diabetes management solutions for pets.

In Europe, countries such as the United Kingdom, Germany, France, and Italy have a growing market for pet diabetes care devices, driven by increasing pet ownership, rising awareness of pet health issues, and expanding veterinary services. The region’s stringent regulatory standards ensure the safety and efficacy of diabetes care devices, contributing to their widespread adoption among pet owners and veterinarians.

In the Asia Pacific region, particularly countries like Japan, Australia, and South Korea, the Pet Diabetes Care Devices Market is witnessing rapid growth due to the rising disposable incomes, changing lifestyles, and growing pet humanization trends. Increasing urbanization and nuclear family structures have led to higher demand for pet companionship and healthcare services, including diabetes management. However, market growth in some developing countries may be hindered by limited access to advanced veterinary care and affordability issues among pet owners.

Latin America and the Middle East & Africa regions are also experiencing growth in the Pet Diabetes Care Devices Market, albeit at a slower pace compared to other regions. Factors such as improving pet healthcare infrastructure, rising pet ownership rates, and growing awareness of pet health issues are driving market expansion in these regions. However, challenges related to economic instability, limited access to veterinary services, and cultural attitudes towards pet ownership may pose barriers to market growth in certain countries.

Pet Diabetes Care Devices Market Scope

Report CoverageDetails
Growth Rate from 2024 to 2033CAGR of 7.05%
Global Market Size in 2023USD 2.48 Billion
Global Market Size by 2033USD 4.91 Billion
U.S. Market Size in 2023USD 640 Million
U.S. Market Size by 2033USD 1,270 Million
Base Year2023
Forecast Period2024 to 2033
Segments CoveredBy Device, By Animal, and By End-use
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Pet Diabetes Care Devices Market Dynamics

Drivers:

Several drivers are fueling the growth of the Pet Diabetes Care Devices Market. Firstly, the increasing prevalence of pet diabetes, attributed to factors such as pet obesity, aging pet population, genetic predisposition, and environmental factors, is driving the demand for diabetes management solutions. As more pets are diagnosed with diabetes, there is a growing need for glucose monitoring systems, insulin delivery devices, and other related products to ensure effective disease management and improved quality of life for diabetic pets.

Moreover, the growing awareness of pet health issues and the importance of regular veterinary care among pet owners are driving the adoption of pet diabetes care devices. Pet owners are increasingly proactive about monitoring their pets’ health and seeking appropriate medical interventions, including diabetes management, to address health concerns and ensure their pets’ well-being.

Furthermore, advancements in veterinary medicine and technology have led to the development of innovative pet diabetes care devices that offer enhanced functionality, convenience, and accuracy in diabetes management. Continuous glucose monitoring systems, smart insulin pumps, and telemedicine platforms enable more efficient and personalized care for diabetic pets, leading to greater acceptance and adoption of these devices among veterinarians and pet owners.

Additionally, the expanding pet insurance coverage and reimbursement options for veterinary care, including diabetes management, are driving market growth by reducing financial barriers to accessing diabetes care devices. Pet insurance providers increasingly cover the costs of diabetes-related treatments and devices, making them more affordable and accessible to pet owners, thereby encouraging greater adoption of diabetes management solutions for pets.

Furthermore, the pet humanization trend, characterized by increased spending on pet healthcare, premium pet food, and other pet-related products and services, is contributing to market growth by fostering greater investment in pet diabetes care devices. Pet owners are willing to invest in high-quality medical devices and treatments to ensure the health and well-being of their pets, including those diagnosed with diabetes, driving demand for advanced diabetes management solutions.

Opportunities:

The Pet Diabetes Care Devices Market offers significant opportunities for manufacturers, veterinarians, and pet owners to improve diabetes management and enhance the quality of life for diabetic pets. Firstly, there is a growing demand for advanced glucose monitoring systems that offer real-time, continuous monitoring of blood glucose levels in diabetic pets. Continuous glucose monitoring devices provide valuable insights into glucose fluctuations, enabling more precise insulin dosing and better glycemic control, thereby reducing the risk of hypoglycemia and hyperglycemia in diabetic pets.

Moreover, there is an increasing need for user-friendly insulin delivery devices that facilitate accurate and convenient insulin administration for diabetic pets. Insulin pens, syringes, and pumps designed specifically for veterinary use offer ease of use, dose accuracy, and precise insulin delivery, enhancing compliance and treatment outcomes in diabetic pets.

Furthermore, there is a growing demand for telemedicine platforms and remote monitoring solutions that enable veterinarians to remotely assess and manage diabetic pets’ health status. Telemedicine platforms facilitate virtual consultations, remote glucose monitoring, and personalized treatment adjustments, allowing veterinarians to provide timely and proactive care for diabetic pets, particularly those in remote or underserved areas.

Additionally, there is a rising interest in personalized nutrition and lifestyle interventions for diabetic pets, aimed at optimizing their health and well-being. Customized diet plans, exercise regimens, and weight management programs tailored to diabetic pets’ individual needs can help improve glycemic control, reduce insulin requirements, and minimize the risk of diabetes-related complications.

Read Also: Vibration Sensor Market Size to Attain USD 12.44 Bn by 2033

Recent Developments

  • In November 2023, Boehringer Ingelheim got approval for SENVELGO® in Europe. This is the first oral liquid medication available for diabetic cats, and it represents a significant advancement in treating feline diabetes in Europe. SENVELGO® can be given to cats once a day, either mixed with a small amount of food or directly administered into their mouth.
  • In May 2023, UBI introduced the Petrackr, a diabetes monitoring device for pets. The product consists of a device and single-use test strips for collecting a small drop of blood sample and a hand-held monitor that can supervise multiple profiles of pets. The device accurately tracks, monitors, and displays the blood glucose levels of pets. The product has distribution partnerships in the United States and Canada.
  • In Feb 2023, ALRT, a Singapore-based medical device company, launched GluCurve Pet CGM. It is a continuous monitoring device for diabetic cats and dogs produced in collaboration with Covetrus. It is designed to make diabetes management more effortless.

Pet Diabetes Care Devices Market Companies

  • Merck animal health
  • Becton
  • Fitbark
  • TaiDoc
  • Dickinson
  • Allison Medical
  • Henry Schein
  • Zoetis
  • Ulticare
  • Boehringer Ingelheim Vetmedica Inc.
  • IDEXX Laboratories
  • Johnson & Johnson Services, Inc
  • Novo Nordisk
  • Eli Lilly and Company
  • Vetoquinol S.A.

Segments Covered in the Report

By Device

  • Glucose Monitoring Devices
  • Insulin Delivery Devices
  • Insulin Delivery Pen
  • Insulin Delivery Syringes

By Animal

  • Dogs
  • Cats
  • Horses

By End-use

  • Veterinary Clinics
  • Home Care Settings
  • Veterinary Hospitals

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/